Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Bazin

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Nature|July 21, 2006
Seismic reflection images of the Moho underlying melt sills at the East Pacific RiseS C Singh, A J Harding, G M Kent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerT R J Evans, E Van Cutsem, M J Moore, et al.
Voprosy Onkologii|May 29, 2015
[Possibilities of stereotactic radiotherapy in the palliative treatment of patients with pancreatic cancer]S I Tkachev, S V Medvedev, Ya R Znatkova, et al.
Journal of Hepatology|February 20, 2025
A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancerJennifer J Knox, Mairéad G McNamara, Igor S Bazin, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Nature|July 21, 2006
Seismic reflection images of the Moho underlying melt sills at the East Pacific RiseS C Singh, A J Harding, G M Kent, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2016
Phase 2 placebo-controlled, double-blind trial of dasatinib added to gemcitabine for patients with locally-advanced pancreatic cancerT R J Evans, E Van Cutsem, M J Moore, et al.
Voprosy Onkologii|May 29, 2015
[Possibilities of stereotactic radiotherapy in the palliative treatment of patients with pancreatic cancer]S I Tkachev, S V Medvedev, Ya R Znatkova, et al.
Journal of Hepatology|February 20, 2025
A phase III randomized study of first-line NUC-1031/cisplatin vs. gemcitabine/cisplatin in advanced biliary tract cancerJennifer J Knox, Mairéad G McNamara, Igor S Bazin, et al.
Pageof 8